The cell cycle inhibitors p21
Mammalian cell proliferation, differentiation and death are regulated by similar molecular mechanisms that are modified by carcinogenesis. Cell cycle progression is monitored by multiple checkpoint mechanisms for ensuring its correct development. The main players of these mechanisms are the cyclin-dependent kinases (CDKs), which bind to regulatory units, named cyclin-forming heterodimeric complexes known as CDK/cyclin complexes. CDKs are also regulated by phosphorylation and negatively regulated by their inhibitors or cyclin-dependent kinase inhibitors (CKIs).
p21
Waf1/Cip1 (hereafter referred to as p21) was the first CKI to be identified and a member of the Cip/Kip family, which also includes p27 Kip1 and p57 Kip2 (ref.
2). There are many CKIs, but only p21 has a universal inhibitory activity toward all main CDK complexes. 3 In addition, p21 can act as a tumor suppressor and occasionally as an oncogene. As a tumor suppressor, it inhibits CDK2-cyclin E complex, involved in the G1-S phase transition of the cell cycle and CDK1-cyclin A and/or CDK2-cyclin A, required for the passage from S to G2 phase, causing a solid stop cell proliferation. 4 At the same time, p21 binds to proliferating cell nuclear antigen, blocking its ability to activate replicative DNA polymerase d and inhibiting DNA replication. 5 The oncogenic activity of p21 lies in the activation of CDK4/6-cyclin D complexes, 6 involved in the early G1 phase by promoting cell cycle progression, and the antiapoptotic capacity of p21. 7, 8 Cytoplasm-localized p21 inhibits the activity of proteins involved in apoptosis, including procaspase-3, caspase-8, caspase-10, stress-activated protein kinases and apoptosis signal-regulating kinase 1.
9,10
The first genetic evidence of the involvement of p21 as a tumor suppressor was observed in p21 knockout mouse model that developed spontaneous tumors in aged animals. 11 It is known that p21 acts in synergy with other tumor suppressors in different animal models. In p18
Ink4c -p21 doublenull mice, the presence of p21 accelerates the incidence of pituitary adenomas and lung bronchoalveolar adenomas, 12 and in p53-deficient mice increases the frequency of lymphomas and sarcomas. 13 In p15
Ink4a
-null mice, the lack of p21 increases the number of fibrosarcomas and rhabdomyosarcomas 14 and, combined with Atm deficiency, enhances the frequency of sarcomas, myeloid leukemias, hepatomas and teratomas.
p27
Kip1 (hereafter referred to as p27), another Cip/Kip family member, has a significant role on cell cycle regulation based on its potent inhibitory activity of CDK2-cyclin E, which results in G1 arrest. 16 Beyond its cell cycle regulation, p27 is also involved in the regulation of other cellular processes such as apoptosis or cell motility, which can be oncogenic under certain circunstances. Thus, cytoplasmic p27 modulates actin dynamics by direct regulation of RhoA pathway. 17 Moreover, mislocalization of p27 in the cytoplasm of neoplastic cells is correlated with high degree of malignancy and poor prognosis in some types of human cancer. [18] [19] [20] [21] [22] p27-deficient mice develop multiorgan hyperplasia and pituitary tumors. [23] [24] [25] This deficiency also seems to have an important role in the spontaneous development of T-cell lymphomas in CD2-cyclin E transgenic mice. 26 Moreover, in an p16
Ink4a

/p19
Arf -null mice, p27 deficiency triggers tumor development, induces a higher incidence of lymphomas and significantly increases metastasis. In contrast, p21 deficiency in p16
Ink4a
/p19
Arf mutants does not seem to affect mice survival but changes the tumor range, increasing the incidence of fibrosarcomas.
14 Similarly, mice lacking p27 and CDK4 mutated in R24C position developed a wide spectrum of tumors, including pituitary tumors, with short latency and high penetrance. 27 Therefore, there are multiple evidences for the role that either p21 or p27 has in tumorigenesis, alone or in combination with other tumor suppressors and oncogenes. 14, [28] [29] [30] [31] In addition, CDK-independent functions have been described for p21 and p27, highlighting their role as oncogenes or in cellular stress in different tissues, implicating p21 and p27 as possible therapeutic targets in some processes. 32, 33 Up to now, no studies have been described using a doublenull murine model for p21 and p27. Thus, the main aim of our work is to study the possible oncogenic cooperation of both CDKIs, analyzing the susceptibility to spontaneous tumorigenesis in a double-null murine model generated in our laboratory.
We have reported previously that in p21-null mice there is a delay in the development of radiation-induced thymic lymphomas due to the potent apoptotic response observed in the thymus, which is independent of p53. 8, 11 On that basis, we wondered whether p21p27 double-null mice could have a decreased susceptibility to radiation-induced carcinogenesis. For this reason, we have also performed a g-radiationinduced thymic lymphoma in mice deficient in p21 and p27 CKIs.
MATERIALS AND METHODS Mice
The generation of double-knockout mice for p21 and p27 proteins was initiated by mating p27 knockout male mice with p21 knockout females in a C57BL/6J homogeneous genetic background. The absence of p27 causes female sterility due to an ovulatory defect. 23 Because of this, p21p27 double-KO males were mated to p21 KO p27 þ /À females to generate p21p27 double-mutant mice. All the animals were housed in a pathogen-free barrier area at the Barcelona Biomedical Research Park (PRBB).
For g-radiation-induced tumorigenesis, 1-month-old mice of the different genotypes (p21À/Àp27À/À, n ¼ 6; p21À/À, n ¼ 6; p27À/À, n ¼ 6; and C57BL/6J wild-type mice, n ¼ 6) were irradiated once a week for 4 
PCR Genotyping
Samples of tail were taken from all mice and genomic DNA extracted for genotyping by PCR (Figure 1 ). Independent PCR reactions were assembled for each allele.
Detection of p21 wild-type allele and p21-null allele used a common sense primer (5 0 -AAGCCTTGATTCTGATGTGGG C-3 0 ). The antisense primers used were specific for the p21 wild-type allele (5 0 -TGACGAAGTCAAAGTTCCACCG-3 0 ) and the p21 knockout allele (5 0 -GCTATCAGGACATAGCGTT GGC-3 0 ). In the case of p27, the sense primers used were (5 0 -TGTCA AACGTGAGAGTGTCTAACGG-3 0 ) for the wild-type allele and (5 0 -TGGAACCCTGTGCCATCTCTAT-3 0 ) for the p27-null allele. The antisense primers were (5 0 -AACCCAGCCTGA TTGTCTGACGAG-3 0 ) for the wild-type and (5 0 -CCTTCTAT CGCCTTCTTGACG-3 0 ) for p27-null allele. All the primers for PCR genotyping were used at 0.5 mM final concentration. PCR buffer (10 Â ): 750 mM Tris-HCl (pH 9.0), 500 mM KCl, 200 mM (NH 4 ) 2 SO 4 and 2 mM dNTPs. The MgCl 2 final concentrations used were 3, 1.5, 2.5 and 2 mM for the p21WT, p21 KO, p27WT and p27 KO alleles, respectively. A amount of 0.6 U Biotools DNA polymerase (Biotools B&M Labs, SA, Madrid, Spain) was used per sample. In the case of the p21WT allele, 5% DMSO was included in the PCR reaction.
Thermocycling: step 1, 2 min at 93 1C; step 2, 40 cycles of 30 s at 93 1C, 30 s at 55 1C and an extension of 1 min and 10 s (for p21 KO genotypes) or 1 min (for p27 KO genotypes) at 72 1C; and step 3, 10 min at 72 1C. The DNA bands were separated in a 1% agarose gel ( Figure 1 ), being the sizes of about 900 and 700 bp (for p21WT and KO alleles, respectively) and 500 and 700 bp (for p27WT and KO alleles, respectively).
Necropsy and Pathological Analysis
Mice were monitored daily and killed at any sign of disease. Tissue samples were fixed in 10% buffered formalin, dehydrated in increasing concentrations of ethanol, embedded in paraffin wax, sectioned at 4 mm and stained with hematoxylin and eosin.
Immunohistochemical staining was performed using the streptavidin-biotin-peroxidase complex method. Tissue sections were processed with 10 mM citrate buffer (pH 6.0) in a microwave (100 1C, 15 min). Endogenous peroxidase activity was inactivated by incubation with 3% hydrogen peroxide in methanol (15 min, room temperature). Tissue sections were incubated in a humidified chamber (overnight, 4 1C) using the following antibodies: rabbit anti ACTH (1/100; Abcam, Cambridge, UK), rabbit anti-b-endorphin (1/50; PROGEN Biotechnik GmbH, Heidelberg, Germany), goat anti-prolactin (1/10; R&D Systems, MN, USA), rabbit anti-chromogranin-A (1/400; Abcam), rabbit anti-Pax5 (1/10; Novus Biologicals, CO, USA), rabbit anti-CD3 (1/300; Abcam), rat anti-F4/80 (clone C1:A3-1; 1/10; Serotec, Dusseldorf, Germany), rabbit anti-cleaved PARP1 (1/100; Abcam), rabbit anti-active caspase-3 (1/1000; R&D Systems) and rabbit anti-Ki67 (1/800; Novocastra, Newcastle upon Tyne, UK).
The antibodies were diluted in Tris-buffered saline (TBS). For negative controls, primary antibodies were replaced by nonimmune serum. After three rinses in TBS (5 min each), samples were incubated with the secondary antibody. For detecting primary rabbit, goat and rat antibodies, we used biotinylated goat anti-rabbit IgGs, rabbit anti-goat IgGs and rabbit anti-rat IgGs, respectively (1:400; Vector Laboratories, Burlingame, CA). After 30 min incubation with the secondary antibody, tissue sections were washed in TBS (5 min, 3 times) and immediately incubated for 30 min with streptavidin-peroxidase complex diluted 1:400 in TBS (Zymed Laboratories, Invitrogen, CA, USA). The chromogen was 3-3 0 -diaminobenzidine (DAB peroxidase substrate kit, Vector Laboratories). Nuclei were counterstained with Harris hematoxylin for 1 min. Images were captured with a DP-10 digital camera in Olympus Vanox microscope at Â 4, Â 10 and Â 20 magnifications.
In g-radiation-induced thymic lymphomas, the apoptotic index, measured by the percentage of active caspase-3 and cleaved PARP-1-positive cells, and the proliferation index (Ki67-positive cells) were obtained by counting 500 cells per high-power field in five fields of each tumor section.
Statistical Analysis
Survival data were analyzed using Kaplan-Meier survival analysis (SPSS14 and MedCal) and compared using a w 2 -test. Results were expressed as mean ± s.e.m. and considered statistically significant when Po0.05.
RESULTS
Study of Spontaneous Tumor Development in p21p27 Double-Null Mice
Animal survival A 2-year comparative study was performed in a colony of double-null mice for p21 and p27 (n ¼ 18) and two more colonies of p21-null mice (n ¼ 20) and p27-null mice (n ¼ 18). p21p27 double-null mice phenotype was indistinguishable from their wild-type littermates; body and organs weight showed standards values.
The median survival time for p21p27 double-null was 11.6 months, slightly lower than for p27-null animals (12.6 months), and significantly lower than for p21-null mice, the median survival time of which was 15.6 months (Po0.001; Figure 2 ). In the latter group, three female died quite early (8 months), because of a severe glomerulonephritis, a common disease in p21-deficient female mice.
Spontaneous tumor development in p21p27 double-null mice
The absence of p21 and p27 CKIs lead to the development of tumors with an incidence of 72.2% and an average tumor latency of 11.6. months. In comparison, p21-null mice showed a tumor incidence of 55% with a mean latency of 15.4 months whereas only 50% of the p27-null mice developed tumors with an average tumor latency of 12.6 months ( Table 1) . Relative tumor incidence is show in Figure 3 .
Spontaneous tumor spectrum in p21p27 double-null mice Histopathological analysis of the spontaneously developed neoplasias in p21p27 double-null mice revealed a broad tumor spectrum (Figure 4) . Pituitary tumors were the most frequently observed malignancies, accounting for 33.3%. These neoplasias were composed of polygonal cells arranged in solid sheets intermingled with fibrovascular stroma. Tumor cells were atypical, with irregular protrusions and pleomorphic nuclei, allowing a diagnosis of pituitary adenomas. They also tended to form hemorrhagic cysts (Figure 4a ). The pituitary tumors stained positive for ACTH and b-endorphin, two of the proopiomelanocortin-derived peptides produced in the pars intermedia of the pituitary gland. Tumor cells were negatives for prolactin expression.
Thyroid adenomas appeared only in two double-mutant mice (11.1%), simultaneously with pituitary adenomas. These tumors were composed of colloid-containing follicles lined by a single layer of epithelial cells (Figure 4b) .
Benign pheochromocytoma was the second most frequently observed tumor (22.2%); it was mainly composed of chromaffin cells of the adrenal gland medulla (Figure 4c) . The tumors found in our study had an expansive growth and were larger than 50% of the normal medulla on histological sections, which is a hallmark in differential diagnosis with medullary hyperplasia in mice. 34 Tumor cells were arranged in nests or trabeculae; they were polygonal with large granular cytoplasm and oval central nuclei. Moderate cellular atypia and a low number of mitosis were seen. These tumors showed strong positive immunoreactivity with anti-chromogranin-A antibody (Figure 4d) . p21p27 double-null mice also developed hematopoietic tumors (16.6%). Two of them were histiocytic sarcomas (11.1%) localized in mesenteric lymph nodes, liver and spleen. These tumors were composed of densely packed histiocytic aggregates that infiltrate the tissues and multinucleated giant cells that can be seen occasionally. Histiocytic sarcomas were strongly positive with anti-F4/80 (Figure 4e ). Only one mouse developed a B-cell lymphoma (5.5%), composed of uniform round cells with a small basophilic cytoplasm and central round nucleus, which diffusely infiltrated lymph nodes and spleen (Figure 4f) .
Finally, other tumors diagnosed were adenoma of the Harderian gland and hepatocellular adenoma (5.5% each) and one mammary adenocarcinoma in a female mouse. Of a total population of 20 animals, 11 developed tumors (55%). c Of a total population of 18 animals, 10 developed tumors (55.5%).
d A broad spectrum of tumor types was detected at relatively low frequencies. These included a malignant mammary carcinoma (5.5% incidence and 6-month latency), a benign Harderian gland adenoma (5.5% incidence and 11-month latency) and a benign hepatocellular adenoma (5.5% incidence and 15-month latency) in p21/p27 double-null mice; a benign lung adenoma (5% incidence and 19-month latency) in p21-null mice; and a benign duodenal adenoma (5.5% incidence and 14-month latency) in p27-null mice.
Spontaneous tumor development in p21-null mice Hematopoietic tumors were the most frequently observed tumor type in p21-null mice, especially histiocytic sarcoma (30%) and B-cell lymphoma (5%).
Hemangiomas were the second most common type of neoplasias (10%). These tumors developed in spleen and liver, and were composed of numerous capillary blood vessels without atypical cells.
p21-null mice also developed some epithelial tumors, such as one pituitary adenoma (5%) and one bronchoalveolar adenoma in the lung (5%).
Spontaneous tumor development in p27-null mice As it has been reported, pituitary adenoma was the most common type of tumor observed in p27-null mice, with an incidence of 27.7% (Table 1) . Interestingly, in our colony we diagnosed pheochromocytomas in three animals, with a latency period of 12.8 months. A single thyroid adenoma was detected (5.5%), with a latency period of 11 months, and a case of intestinal adenoma (5.5%), with a latency period of 14 months.
Study of c-Radiation-Induced Tumorigenesis in p21p27 Double-Null Mice
To study p21p27 double-null mice susceptibility to radiationinduced carcinogenesis, mice of the different genotypes (p21À/Àp27À/À, n ¼ 6; p21À/À, n ¼ 6; p27À/À, n ¼ 6; and C57BL/6J wild-type mice, n ¼ 6) were irradiated once a week for 4 weeks with a dose of 1.75 Gy. Animals were daily checked and killed as soon as dyspnea was present. Thymic lymphomas were the only tumor pathology found at necropsy.
The incidence of T-cell lymphomas was lower in p21 KO and p21p27 double-null mice (30% in both groups) than in the rest of the studied groups (100%; Table 2 ). The development of g-radiation-induced T-cell lymphoma is responsible for the death of p27À/À mice (n ¼ 6) and wildtype mice (n ¼ 6) over a period of 8 months after irradiation ( Figure 5 ). In agreement with this, p21-null mice showed a median survival time significantly higher than p27-null mice and wild-type mice (Po0.001, Figure 5 ). p21p27 double-KO mice showed a significantly higher survival time than p21 þ / þ p27À/À mice (Po0.05) and, although not statistically significant, higher than wild-type animals (P ¼ 0.05).
The apoptotic response in g-irradiated thymic tumors was quantitated by scoring the percentage of cells positive for active caspase-3 and cleaved PARP-1 ( Table 2) . A higher apoptotic rate was observed in p21p27 double-null and p21À/À mice compared with p27 KO mice and wild-type mice ( Figure 6 ). Proliferation index, measured by Ki67 immunostaining, showed no differences among groups ( Figure 6 ).
DISCUSSION
The object of our study was to investigate the existence of oncogenic cooperation between p21 and p27, both members of the Cip/Kip family of CDKIs, generating for this purpose a colony of mice double null for both proteins. This colony has been followed up and analyzed for 24 months. The results showed that the combined absence of both proteins indicates cooperation between them because double-KO mice suffer of a higher tumor incidence and increased penetrance when compared with p21-or p27-deficient mice.
The phenotype of p21p27 double-mutant mice did not show differences with regard to other mice groups of this study. This is most likely because of the fact that, in contrast to that described in a mixed genetic background, [23] [24] [25] in homogeneous C57Bl/6J genetic background no increase in body size is observed in mice lacking p27 protein.
p21p27 double-mutant mice had a median survival time of 11.6 months in a C57BL/6 genetic background. This is significantly lower than the survival of p21-null mice in our study (Po0.001) and their survival in a previous study where p21-null mice were monitored over a period of 16 months. 11 Nevertheless, the median survival time in p21p27 doubledeficient mice did not show significant differences with regard to p27-null mice (12.6 months). Those facts suggest that the lack of p27 determines the survival time in Tumorigenesis p21p27 double-null mice RA García-Fernández et al double-null mice. Our results are in agreement with data from the study of the p27 deficiency combined with the lack of p16
Ink4 -p19
Arf in mice, where the median survival time was only 4.5 months 14 and its combination with the CDK4 KO (6.7 months), 27 results that evidenced the negative effect of p27 deletion over the survival time. Lethality in p21p27 double-null mice was caused by the development of tumors with a latency period of 11 months. Previous research with p27À/À animals showed lower average tumor latency, 27 whereas for p21-null mice the latency period was similar to other published results. 11 p21p27 double-null mice develop a broad spectrum of neoplasias. Endocrine tumors (derived from pituitary, adrenal and thyroid glands) were the most common type found, followed by hematopoietic neoplasias, mainly histiocytic sarcomas and lymphomas.
Pituitary adenomas, arising from the pars intermedia, were the most frequently observed tumors (33.3%) and matched those previously observed in p27-null mice. [23] [24] [25] 32 The second most common tumor type in p21p27 double-KO mice was pheochromocytoma (22.2%), also highly frequent in our p27-null mice in the C57BL/6 genetic background (16.6%). In fact, pheochromocytomas have also been described in p27 ckÀ knock-in mice in 129S4 background. 32 In doublemutant Cdk4 R/R p27 À/À , adrenal medullary hyperplasia and pheochromocytomas have also been described, with significant lower latency period than in the single-mutant Cdk4 R/R or p27 À/À (ref. 27) mice. However, other studies using p27-null mice in 129SV background only described adrenal medullary hyperplasia, 24 or did not make any reference to the development of pretumoral or tumoral lesions in the adrenal gland. 23, 25 This could be related to the different genetic backgrounds used to create the different lines or could be associated with the histological criteria applied to differentiate hyperplasias from neoplasias in the mouse adrenal gland. 34 Other epithelial tumor developed in mice double deficient in p21 and p27 proteins was located in thyroid glands. In this type of neoplasias, the impairment of p27 function has been reported as being very frequent. 35 Recent studies have demonstrated that the loss of p27 in mice, with targeted overexpression of TRK-T1 oncogene, enhances thyroid carcinogenesis. 36 The most common hematopoietic tumor diagnosed in double-deficient mice was histiocytic sarcoma. This tumor was also the most frequent type observed in p21-null mice in our study as well as in others previously published. 11 Interestingly, lymphomas do not develop spontaneously in p27-null mice, [23] [24] [25] but they were detected in p21p27 doublenull mice (5.5%). 26, 36 The broad tumor spectrum observed in p21p27 doubledeficient murine model has some resemblances with human neoplasias. Although mutation of p21 or p27 genes is rare in human cancer, decreased levels of expression of these proteins correlate with poor prognosis. Thus, reduced p21 levels were observed in colorectal cancer 37, 38 and have been used as a predictor of poor prognosis in human breast cancer 39, 40 and hepatocarcinoma. 41 At this point, it is important to consider that p21 is the major transcriptional target of the tumor suppressor gene p53, frequently mutated in human cancer. Additionally, p27 deficiency has been reported in many human tumors of breast, colon and lungs. [42] [43] [44] p21p27 double-null mice demonstrate the oncogenic cooperation between both CKIs, as p21 deficiency only leads to the development of tumors in aged animals, 11 whereas p27-null mice develop only benign pituitary adenomas. [23] [24] [25] The deletion of p21 in this model has a role as a tumorigenesis enhancer similar to that when it is combined with p18
Ink4c À/À mice, 12 Atm-null mice 15 or Trp53 À/À mice. 8 The wide variety of tumors that spontaneously develop in double-KO mice suggests that p21 and p27 proteins are p21+/+p27+/+ 100% (6/6) 11 22 42 Each tumour from each genotype (p21p27 double-null mice, n ¼ 2; p27 KO mice, n ¼ 2; p21 KO mice, n ¼ 4; and wild-type, mice n ¼ 4) was analyzed by counting 500 cells in five fields. involved in cell cycle regulation, transformation and cancer development in most cell types. 10, 32, 45 p21p27 double-null mice exposed to g-radiation were more resistant to neoplasias than wild-type or p27-null mice, and showed a higher survival rate post irradiation. This could be explained by the loss of the antiapoptotic effect after p21 ablation, as it has been shown in previous studies performed in p21-null mice, where animals developed an effective apoptotic response in the thymus. 11 Our results show the existence of an active apoptotic response in p21p27 doublenull thymic lymphomas using active caspase-3 and cleaved PARP-1 as markers.
To summarize, p21p27 double-null murine model shows high tumor incidence and develops a broad range of neoplasias. This leads to an increase in lethality, demonstrating the cooperative role of p21 and p27 CKIs in tumor suppression.
